Liver condition in pregnant women at a hospital
This study looks at liver problems in pregnant women. If you have elevated liver enzymes or bilirubin, joining may help researchers learn more about how to manage liver health during pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be pregnant and 18 years or older.
- You must have high levels of liver enzymes or bilirubin (a yellow pigment in the blood).
- You must not have a bile duct or gallbladder infection or inflammation.
- You must agree to be part of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often liver enzyme (ALT) levels rise in women with chronic hepatitis B after they give birth, and what factors might predict this. It aims to help guide care after delivery.
This study looks at bile acid levels in pregnant women who have intrahepatic cholestasis of pregnancy (ICP), a liver condition that causes itching and can affect the baby. It also includes two control groups: healthy pregnant women and healthy non-pregnant women for comparison.
This study looks at whether a pregnancy liver condition called intrahepatic cholestasis of pregnancy is linked with chronic inflammation in the placenta. It may help doctors better understand risks and what to monitor during pregnancy.
This study looks at how a pregnancy liver condition (intrahepatic cholestasis) affects the baby's breathing after birth. It compares newborns whose mothers had this condition (and took medication for it) with newborns whose mothers did not have any liver issues during pregnancy.
This study looks at how certain blood tests (liver biomarkers) change in people with higher risk for liver disease. It may help doctors understand who is developing liver problems earlier and what patterns in blood tests matter most.
This study follows babies under 6 months old who have early signs of liver disease (cholestasis) to better understand what causes it and how it progresses. Researchers will collect medical information over time to improve diagnosis and treatment.
Hear when a new Liver Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.